DDX21 and colorectal cancer: Gene effect scores for DDX21 and BIRC5, derived from CRISPR-Cas9 loss-of-function screens across 40 colorectal cancer (CRC) cell lines in the Achilles project, were −0.8 and −1.5, respectively.